
Alioth
艾里奥斯生物科技(上海)有限公司,专注于制药过程过滤产品及技术的开发和应用,并致力于为制药企业提供符合国内外法规要求的高质量的分离、纯化解决方案。 艾里奥斯聚焦“膜材料”技术的创新与突破,在美国波士顿和中国上海组建了由国际知名膜技术科学家领衔的研发团队,持续研发具有自主知识产权的高性能过滤膜材和过滤器产品,为制药企业的过滤工艺优化保驾护航。 同时,艾里奥斯遵循ISO9001质量体系并参考GMP要求,在上海等地自建了超过15,000m2的过滤膜和过滤器生产基地,拥有通过CNAS认证的验证中心、工艺开发实验室等配套设施,以更好地保障制药企业的供应链安全和药品生产安全,助力制药企业的创新发展。
$14.35M Series B+ ·
Source: aliothbio.com
Funding history ↓Signals
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | $14.35M | — | aliothbio.com |
Timeline
- Website created
Investors
Similar Health and bio companies
SSeawolf Therapeutics$100M Seed · Nov 2026
TTestDynamics$9M Series A · Nov 2026
IINFevo$15M Seed · Nov 2026
KKnit Health$35M Seed · Nov 2026
RRemedy Robotics$62M Series A · Nov 2026
VVumedi$140M Series B+ · Nov 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/alioth (get a free API key).